TORC | | resTORbio, Inc. | Orbimed Advisors LLC | Director | Jan 30, 2018 | Conversion | - | 4,297,054 | - | 4,297,054 | Jan 30, 2018, 06:41 PM |
TORC | | resTORbio, Inc. | Orbimed Advisors LLC | Director | Jan 30, 2018 | Buy | $15.00 | 533,333 | 7,999,995 | 4,830,387 | Jan 30, 2018, 06:41 PM |
SYBX | | SYNLOGIC, INC. | Orbimed Advisors LLC | Director | Jan 26, 2018 | Award/Grant | $9.75 | 715,000 | 6,971,250 | 2,029,996 | Jan 30, 2018, 04:30 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 26, 2018 | Buy | $14.93 | 22,760 | 339,807 | 2,972,760 | Jan 30, 2018, 03:34 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 29, 2018 | Buy | $14.99 | 50,000 | 749,500 | 3,022,760 | Jan 30, 2018, 03:34 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 12, 2018 | Buy | $14.50 | 38,354 | 556,133 | 2,731,069 | Jan 24, 2018, 08:59 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 19, 2018 | Buy | $14.95 | 74,931 | 1,120,218 | 2,806,000 | Jan 24, 2018, 08:59 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 22, 2018 | Buy | $14.98 | 75,000 | 1,123,500 | 2,881,000 | Jan 24, 2018, 08:59 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 23, 2018 | Buy | $14.99 | 4,363 | 65,401 | 2,885,363 | Jan 24, 2018, 08:59 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 24, 2018 | Buy | $14.91 | 64,637 | 963,738 | 2,950,000 | Jan 24, 2018, 08:59 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 12, 2018 | Buy | $15.40 | 28,446 | 438,068 | 2,692,715 | Jan 12, 2018, 05:29 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 10, 2018 | Buy | $12.83 | 170,338 | 2,185,437 | 2,622,569 | Jan 12, 2018, 05:29 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jan 11, 2018 | Buy | $13.65 | 41,700 | 569,205 | 2,664,269 | Jan 12, 2018, 05:29 PM |
PIRS | | PIERIS PHARMACEUTICALS, INC. | Orbimed Advisors LLC | 10% Owner | Jan 03, 2018 | Sale | $7.35 | 1,709,620 | 12,565,707 | 5,500,730 | Jan 04, 2018, 03:23 PM |
PIRS | | PIERIS PHARMACEUTICALS, INC. | Orbimed Advisors LLC | 10% Owner | Dec 18, 2017 | Option/RSU Exercise | $2.09 | 147,635 | 308,052 | 7,340,465 | Dec 20, 2017, 05:12 PM |
PIRS | | PIERIS PHARMACEUTICALS, INC. | Orbimed Advisors LLC | 10% Owner | Dec 18, 2017 | Sale | $5.70 | 147,635 | 841,519 | 7,194,222 | Dec 20, 2017, 05:12 PM |
SCPH | | scPharmaceuticals Inc. | Orbimed Advisors LLC | 10% Owner | Nov 21, 2017 | Conversion | - | 2,576,532 | - | 2,576,532 | Nov 21, 2017, 07:13 PM |
SCPH | | scPharmaceuticals Inc. | Orbimed Advisors LLC | 10% Owner | Nov 21, 2017 | Buy | $14.00 | 833,333 | 11,666,662 | 3,409,865 | Nov 21, 2017, 07:13 PM |
ASNS | | Arsanis, Inc. | Orbimed Advisors LLC | 10% Owner | Nov 20, 2017 | Conversion | $2.68 | 1,868,966 | 5,000,000 | 1,868,966 | Nov 20, 2017, 05:32 PM |
RYTM | | RHYTHM PHARMACEUTICALS, INC. | Orbimed Advisors LLC | 10% Owner | Oct 10, 2017 | Conversion | - | 2,546,295 | - | 2,546,295 | Oct 10, 2017, 04:21 PM |
RYTM | | RHYTHM PHARMACEUTICALS, INC. | Orbimed Advisors LLC | 10% Owner | Oct 10, 2017 | Buy | $17.00 | 355,000 | 6,035,000 | 2,901,295 | Oct 10, 2017, 04:21 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 31, 2017 | Sale | $37.82 | 44,922 | 1,698,950 | 1,358,833 | Sep 05, 2017, 09:27 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Sep 01, 2017 | Sale | $37.72 | 110,078 | 4,152,142 | 1,249,793 | Sep 05, 2017, 09:27 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Sep 05, 2017 | Sale | $39.09 | 425,200 | 16,621,730 | 1,076,444 | Sep 05, 2017, 09:27 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 15, 2017 | Sale | $38.29 | 32,500 | 1,244,425 | 1,693,072 | Aug 17, 2017, 05:20 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 16, 2017 | Sale | $38.01 | 65,580 | 2,492,696 | 1,628,111 | Aug 17, 2017, 05:20 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 17, 2017 | Sale | $37.85 | 226,920 | 8,588,922 | 1,403,331 | Aug 17, 2017, 05:20 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jul 25, 2017 | Conversion | - | 2,055,946 | - | 2,055,946 | Jul 27, 2017, 07:17 PM |
KALA | | Kala Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Jul 25, 2017 | Buy | $15.00 | 319,333 | 4,789,995 | 2,375,279 | Jul 27, 2017, 07:17 PM |
ADAP | | Adaptimmune Therapeutics PLC | Orbimed Advisors LLC | Director | Mar 27, 2017 | Buy | $4.20 | 1,190,476 | 4,999,999 | 6,149,377 | Mar 28, 2017, 06:48 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Mar 14, 2017 | Sale | $44.54 | 74,100 | 3,300,414 | 1,725,265 | Mar 14, 2017, 07:39 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Mar 10, 2017 | Sale | $45.98 | 97,028 | 4,461,347 | 2,008,071 | Mar 14, 2017, 07:39 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Mar 13, 2017 | Sale | $45.30 | 211,410 | 9,577,454 | 1,799,359 | Mar 14, 2017, 07:39 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Mar 03, 2017 | Sale | $47.05 | 55,772 | 2,624,073 | 2,104,184 | Mar 07, 2017, 06:48 PM |
AGLE | | Aeglea BioTherapeutics, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 16, 2017 | Buy | $5.04 | 30,500 | 153,720 | 1,390,724 | Feb 21, 2017, 05:58 PM |
AGLE | | Aeglea BioTherapeutics, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 17, 2017 | Buy | $5.19 | 71,800 | 372,642 | 1,462,524 | Feb 21, 2017, 05:58 PM |
AGLE | | Aeglea BioTherapeutics, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 21, 2017 | Buy | $5.36 | 7,000 | 37,520 | 1,469,524 | Feb 21, 2017, 05:58 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 10, 2016 | Sale | $33.77 | 117,938 | 3,982,766 | 2,332,779 | Aug 12, 2016, 08:35 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 11, 2016 | Sale | $33.63 | 160,900 | 5,411,067 | 2,173,397 | Aug 12, 2016, 08:35 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 12, 2016 | Sale | $33.72 | 14,100 | 475,452 | 2,159,430 | Aug 12, 2016, 08:35 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Aug 03, 2016 | Sale | $30.59 | 425,000 | 13,000,750 | 2,449,604 | Aug 05, 2016, 04:05 PM |
SELB | | SELECTA BIOSCIENCES INC | Orbimed Advisors LLC | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 08:55 PM |
SELB | | SELECTA BIOSCIENCES INC | Orbimed Advisors LLC | Director | Jun 27, 2016 | Conversion | - | 1,177,995 | - | 1,280,604 | Jun 29, 2016, 08:55 PM |
SELB | | SELECTA BIOSCIENCES INC | Orbimed Advisors LLC | Director | Jun 27, 2016 | Conversion | - | 1,177,995 | - | 1,280,604 | Jun 29, 2016, 04:49 PM |
SELB | | SELECTA BIOSCIENCES INC | Orbimed Advisors LLC | Director | Jun 27, 2016 | Buy | $14.00 | 550,000 | 7,700,000 | 1,825,415 | Jun 29, 2016, 04:49 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:47 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:47 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 06:55 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 06:55 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 05:59 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 05:59 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 05:59 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:18 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:18 PM |
ADAP | | Adaptimmune Therapeutics PLC | Orbimed Advisors LLC | Director | May 20, 2016 | Buy | $10.04 | 2,400 | 24,096 | 28,043,404 | May 25, 2016, 06:41 PM |
ADAP | | Adaptimmune Therapeutics PLC | Orbimed Advisors LLC | Director | May 23, 2016 | Buy | $10.40 | 1,191,600 | 12,392,640 | 29,235,004 | May 25, 2016, 06:41 PM |
ADAP | | Adaptimmune Therapeutics PLC | Orbimed Advisors LLC | Director | May 24, 2016 | Buy | $10.48 | 518,400 | 5,432,832 | 29,753,404 | May 25, 2016, 06:41 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:37 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 05:21 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 05:21 PM |
NTLA | | Intellia Therapeutics, Inc. | Orbimed Advisors LLC | Director | May 11, 2016 | Conversion | - | 2,412,180 | - | 2,412,180 | May 13, 2016, 04:58 PM |
NTLA | | Intellia Therapeutics, Inc. | Orbimed Advisors LLC | Director | May 11, 2016 | Buy | $18.00 | 250,000 | 4,500,000 | 2,662,180 | May 13, 2016, 04:58 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:21 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC | Director | Mar 29, 2016 | Conversion | - | 4,708,450 | - | 4,708,450 | Mar 29, 2016, 12:21 PM |
PIRS | | PIERIS PHARMACEUTICALS, INC. | Orbimed Advisors LLC | Director | Jul 06, 2015 | Buy | $2.75 | 500,000 | 1,375,000 | 7,194,222 | Jul 08, 2015, 05:46 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Jun 30, 2015 | Option/RSU Exercise | - | 27,607 | - | 2,882,216 | Jun 30, 2015, 05:51 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Jun 30, 2015 | Conversion | - | 2,882,064 | - | 2,854,870 | Jun 30, 2015, 05:51 PM |
GKOS | | GLAUKOS Corp | Orbimed Advisors LLC | Director | Jun 30, 2015 | Tax Payment (Shares) | $18.00 | 11,734 | 211,212 | 2,870,593 | Jun 30, 2015, 05:51 PM |
SUPN | | SUPERNUS PHARMACEUTICALS INC | Orbimed Advisors LLC | 10% Owner | Feb 12, 2013 | Sale | $7.52 | 152,183 | 1,144,690 | 2,291,900 | Feb 14, 2013, 05:20 PM |
SUPN | | SUPERNUS PHARMACEUTICALS INC | Orbimed Advisors LLC | 10% Owner | Feb 13, 2013 | Sale | $7.58 | 150,000 | 1,136,355 | 2,183,000 | Feb 14, 2013, 05:20 PM |
SUPN | | SUPERNUS PHARMACEUTICALS INC | Orbimed Advisors LLC | 10% Owner | Dec 17, 2012 | Sale | $6.85 | 197,815 | 1,354,617 | 100,000 | Dec 19, 2012, 09:42 PM |
SUPN | | SUPERNUS PHARMACEUTICALS INC | Orbimed Advisors LLC | 10% Owner | Dec 18, 2012 | Sale | $7.08 | 100,000 | 707,670 | 0 | Dec 19, 2012, 09:42 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Sep 04, 2012 | Sale | $14.43 | 233,700 | 3,372,992 | 594,300 | Sep 05, 2012, 05:33 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Jul 27, 2012 | Sale | $14.61 | 3,456 | 50,483 | 7,944 | Jul 30, 2012, 07:26 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Jul 27, 2012 | Sale | $14.61 | 362,844 | 5,300,207 | 825,756 | Jul 30, 2012, 07:26 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Jun 19, 2012 | Sale | $12.91 | 5,900 | 76,185 | 11,400 | Jun 19, 2012, 07:31 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Jun 19, 2012 | Sale | $12.91 | 611,200 | 7,892,242 | 1,188,600 | Jun 19, 2012, 07:31 PM |
SUPN | | SUPERNUS PHARMACEUTICALS INC | Orbimed Advisors LLC | Director | May 04, 2012 | Conversion | - | 2,499,998 | - | 1,668,472 | May 08, 2012, 04:18 PM |
SUPN | | SUPERNUS PHARMACEUTICALS INC | Orbimed Advisors LLC | Director | May 04, 2012 | Buy | $5.00 | 1,100,000 | 5,500,000 | 2,402,600 | May 08, 2012, 04:18 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Mar 09, 2012 | Sale | $11.25 | 37,000 | 416,087 | 2,509,400 | Mar 13, 2012, 06:43 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Mar 12, 2012 | Sale | $11.03 | 63,100 | 696,107 | 2,446,700 | Mar 13, 2012, 06:43 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 29, 2012 | Sale | $10.86 | 3,000 | 32,584 | 2,546,100 | Feb 29, 2012, 09:52 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 27, 2012 | Sale | $11.05 | 29,000 | 320,369 | 2,559,500 | Feb 29, 2012, 09:52 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 28, 2012 | Sale | $11.12 | 10,100 | 112,316 | 2,549,200 | Feb 29, 2012, 09:52 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 01, 2012 | Sale | $11.01 | 70,000 | 770,406 | 2,662,200 | Feb 03, 2012, 09:30 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 02, 2012 | Sale | $10.85 | 23,300 | 252,917 | 2,638,400 | Feb 03, 2012, 09:30 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Feb 03, 2012 | Sale | $10.79 | 50,000 | 539,520 | 2,588,700 | Feb 03, 2012, 09:30 PM |
PCRX | | Pacira Pharmaceuticals, Inc. | Orbimed Advisors LLC | 10% Owner | Oct 31, 2011 | Sale | $10.53 | 97,441 | 1,025,635 | 2,732,387 | Nov 02, 2011, 08:04 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 29, 2011 | Sale | $16.01 | 1,000 | 16,010 | 17,600 | May 03, 2011, 07:26 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 29, 2011 | Sale | $16.01 | 99,000 | 1,584,990 | 1,832,400 | May 03, 2011, 07:26 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | May 02, 2011 | Sale | $16.30 | 300 | 4,890 | 17,300 | May 03, 2011, 07:26 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | May 02, 2011 | Sale | $16.30 | 32,600 | 531,380 | 1,799,800 | May 03, 2011, 07:26 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 20, 2011 | Sale | $15.79 | 7,600 | 120,004 | 25,700 | Apr 26, 2011, 08:21 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 20, 2011 | Sale | $15.79 | 792,400 | 12,511,996 | 2,674,300 | Apr 26, 2011, 08:21 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 21, 2011 | Sale | $16.67 | 742,900 | 12,381,667 | 2,426,667 | Apr 25, 2011, 09:46 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 21, 2011 | Sale | $16.67 | 7,100 | 118,333 | 23,333 | Apr 25, 2011, 09:46 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 18, 2011 | Sale | $15.18 | 28,200 | 428,168 | 44,832 | Apr 20, 2011, 09:39 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 18, 2011 | Sale | $15.18 | 2,971,800 | 45,121,729 | 4,682,029 | Apr 20, 2011, 09:39 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Apr 20, 2011 | Sale | $15.79 | 800,000 | 12,632,000 | 2,674,300 | Apr 20, 2011, 09:39 PM |
AMRN | | AMARIN CORP PLCUK | Orbimed Advisors LLC | Director | Mar 28, 2011 | Sale | $7.35 | 92,200 | 677,670 | 6,438,500 | Mar 28, 2011, 09:41 PM |